A 2020 study conducted by the U.S. Department of Defense entitled, Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017–2018 influenza season by Greg G. Wolff, published in Vaccine, Volume 38, Issue 2, 10 January 2020, Pages 350-354, found that military personnel who had received seasonal flu shots were significantly more susceptible to coronavirus-associated respiratory infections:
Receiving influenza vaccination may increase the risk of other respiratory viruses, a phenomenon known as virus interference. Test-negative study designs are often utilized to calculate influenza vaccine effectiveness. The virus interference phenomenon goes against the basic assumption of the test-negative vaccine effectiveness study that vaccination does not change the risk of infection with other respiratory illness, thus potentially biasing vaccine effectiveness results in the positive direction. This study aimed to investigate virus interference by comparing respiratory virus status among Department of Defense personnel based on their influenza vaccination status. Furthermore, individual respiratory viruses and their association with influenza vaccination were examined.
We compared vaccination status of 2880 people with non-influenza respiratory viruses to 3240 people with pan-negative results. Comparing vaccinated to non-vaccinated patients, the adjusted odds ratio for non-flu viruses was 0.97 (95% confidence interval (CI): 0.86, 1.09; p = 0.60). Additionally, the vaccination status of 3349 cases of influenza were compared to three different control groups: all controls (N = 6120), non-influenza positive controls (N = 2880), and pan-negative controls (N = 3240). The adjusted ORs for the comparisons among the three control groups did not vary much (range: 0.46–0.51).
Receipt of influenza vaccination was not associated with virus interference among our population. Examining virus interference by specific respiratory viruses showed mixed results. Vaccine derived virus interference was significantly associated with coronavirus and human metapneumovirus; however, significant protection with vaccination was associated not only with most influenza viruses, but also parainfluenza, RSV, and non-influenza virus coinfections.
The average age of patients in Italy who have died of COVID-19 infection is 81, most of whom already had other underlying medical conditions.
A whopping 70% of seniors in the U.S. get their annual flu shots, much higher than the general population, and many of them are receiving ‘high dose’ versions of the vaccine.
According to the manufacturers’ package inserts that come with these vaccines, one of the known and not-so-uncommon side effects of these vaccines is stroke in the elderly.
And now we find out that these heavily-promoted seasonal flu shots are making everyone, including the vulnerable elderly, significantly more susceptible to potentially fatal coronavirus lung infections.
Despite these facts, we can expect that during this coronavirus ‘event’, the CDC will promote seasonal flu shots with even greater urgency.
And despite researchers knowing that two common and inexpensive medications can ‘cure’ coronavirus infections, the CDC and hospitals seem to be acting as if these drugs don’t exist, opting to let these COVID-19 patients die while waiting for another ineffective experimental vaccine to hit the market.
The elderly are the greatest expense to the Federal health care budget, so what better way to cut costs than to cull the herd under the fog of this overblown ‘pandemic’?